Trials / Terminated
TerminatedNCT01442402
APOL1 Gene Variants in African American Kidney Transplant Recipients
Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim 1: Determine if there is an association between the APOL1 risk variants and allograft survival and function in African Americans Aim 2: Determine if there is an association between the presence of APOL1 risk variants in an African American kidney transplant recipient and the risk of recurrent disease Aim 3: Investigate mechanisms of APOL1 associated kidney disease by prospectively following African American kidney transplant recipients throughout their clinical course.
Conditions
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2011-09-28
- Last updated
- 2021-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01442402. Inclusion in this directory is not an endorsement.